Medical Letter on the CDC and FDA

Baxter International Inc. - Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products

Biotechnology Business - United BioSource Expands Regulatory Affairs Capabilities

Boca Pharmacal, Inc. - Boca Pharmacal Receives FDA Approval for Carbinoxamine Oral Solution

Breast Cancer - FDA Grants Accelerated Approval of Avastin in Combination With Paclitaxel Chemotherapy for First-Line Treatment of Advanced HER2-Negative Breast Cancer

Breast Cancer - Industry Analyst Available to Comment on Recently Approved Avastin for the Treatment of Breast Cancer

Cancer - Drug for anemic cancer patients raises risk of death

Cancer - IRIS International Announces Successful Completion of Retrospective Study of 85 Post-Prostatectomy Patients Using Its Investigational NADiA(TM) PSA Assay

Cancer - Treatment of First Patient in Phase I Clinical Trial of Bionomics' Anti-Cancer Drug BNC105

Clinical Trial Research - King Pharmaceuticals Reports Year-End and Fourth-Quarter 2007 Financial Results

Depression - AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder

Diabetes - Deal between Freedom Meditech and Battelle Could Lead to Breakthrough in Diabetes Management

Diabetes - PPD Confirms Takeda's NDA Filing of Alogliptin with U.S. Food and Drug Administration

Diabetes - The Diabetes Series 2008: Experts Speak About Developing Diabetes Therapeutics

Drug Development - Arpida Provides Update on Progress of New Drug Application for Intravenous Iclaprim

Dynavax Technologies - Dynavax Names Martin E. Sanders, M.D. Executive Vice President, Chief Development Officer

EpiCept Corporation - EpiCept Announces Non-Binding Opinion by European Regulatory Authority on Ceplene Marketing Application

Erythema - Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals

Heart Attack - Prochymal(TM) Demonstrates Lasting Benefit in Heart Attack Patients; Osiris Receives FDA Clearance to Start Phase II Trial

Heart Failure - Marketing Authorisation Application for Tolvaptan, Otsuka's Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatraemia, Accepted by the European Medicines Agency

Hepatic Encephalopathy - Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET(TM)

Hepatitis C Virus - Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress

Inflammation - Sirion Therapeutics Receives NDA Acceptance and Priority Review From the FDA for Durezol(TM) in the Treatment of Postoperative Ocular Inflammation

Inhalation Solution - Sepracor Inc. Reports 2007 Fourth Quarter and Full-Year Results, Forecasts Stronger Revenue Growth for 2008

Knee Replacement - ConforMIS, Inc. Introduces the First Patient-Specific Unicompartmental Knee Resurfacing Implant on the Market

Microfluids - Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies' Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System

Millennium Research Group - Small-Diameter Dental Implants Increasingly Popular In the US

Non-Small Cell Lung Cancer - Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting

Oral Contraceptives - Duramed's Lo SEASONIQUE(R) NDA Accepted for Filing by FDA

Par Pharmaceutical, Inc. - Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine

Perfusion - Covidien Announces Tentative FDA Approval for Its Generic Myocardial Perfusion Imaging Kit

Post-Approval Summit - Janet Woodcock and Mark McClellan to Deliver Keynotes at 2008 Post-Approval Summit

Prostate Cancer - GTx's Toremifene Citrate 80 mg Meets Primary and Key Endpoints in Phase III Trial in Advanced Prostate Cancer Patients on Androgen Deprivation Therapy

Public Health - CDC Uses CIBER-Built Solution to Alert Public Health Officials and Public Health Departments

Public Health - More Than 250,000 Additional Public Health Workers Needed by 2020 to Avert Public Health Crisis

Regeneron Pharmaceuticals, Inc. - FDA Approves Regeneron's ARCALYST(TM) (rilonacept) for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)

Regulatory Actions - Alchemia Approaching Several Key Milestones in 2008

Regulatory Actions - FDA Accepts for Review OVATION's Two NDA Submissions for Sabril(R)

Restenosis - First Patient Enrolled in Study Evaluating Performance of Spectranetics Laser Ablation Followed by GORE VIABAHN(R) Endoprosthesis with Heparin Bioactive Surface

Rosacea - CollaGenex Pharmaceuticals Signs Merger Agreement with Galderma Pharma S.A.

Schizophrenia - FDA Issues Not-Approvable Letter for Lilly's Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment

Thromboembolism - Drugs used for cancer-associated anemia linked with increased risk of blood clots, death

Weight Loss - eDiets(R) Launches Fresh Meal Delivery Program for alli(R) Users

Women's Health - Folic Acid Action Raises Concerns Over the FSA's Line on Folic Acid Fortification and Supplementation